by Jane Schumacher | Nov 5, 2024
Ben Novak joined Paratek Pharmaceuticals as Senior Director of Government Affairs in September 2024, where his focus is on engaging Congress, HHS, and DOD on important issues around antimicrobial resistance and biodefense preparedness. Prior to join Paratek Ben spent...
by Jane Schumacher | Nov 5, 2024
Dr. Kosaraju is the CEO and President of Phare Bio, a social venture using AI and deep learning to develop novel classes of antibiotics in partnership with Jim Collins’ lab at MIT. Phare is a recipient of TED’s Audacious Project to support powerful solutions to the...
by Luka Srot | Mar 30, 2021
Marc Gitzinger is Chief Executive Officer and co-founder of BioVersys. He has over 10 years of experience in the biotech industry, having launched a university spin-off in the field of antimicrobial resistance and growing it into a multi-asset early clinical stage...
by Danny O'Keefe | Feb 23, 2023
Dr. Vasan Sambandamurthy is Senior Vice President – Strategy & Global Operations at Bugworks Research Inc – a clinical stage biopharmaceutical company that is developing novel class of broad-spectrum antibacterial agents and immunotherapies to treat patients with...
